ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Lyell Immunopharma, INC.

Official 2024 U.S. DOL Form 5500 summary for Lyell Immunopharma, INC. (Lyell Immunopharma, INC. 401(k) Plan · EIN 83-1300510 · PN 001): $28.25M net assets, 200 active participants, and $19.71 per $10,000 (19.71 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorLyell Immunopharma, INC.
Filing IdentifierLyell Immunopharma, INC. 401(k) Plan · EIN 83-1300510 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$28.25M
Active Participants200
Direct Admin Fee Rate$19.71 per $10,000 (19.71 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderFidelity Investments
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI